Sentinel Node in Larynx and Pharynx Cancers
NCT04068636 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2022-04-29
Summary
This study explores the feasibility of sentinel lymph node identification in pharynx and larynx cancers using flexible endoscopy-guided tracer injection.
Conditions
- Head and Neck Cancer
- Lymph Node Metastases
Interventions
- PROCEDURE
-
Radioactive tracer injection via flexible endoscopy and SPECT scan for visualization of lymph nodes.
Flexible endoscopy will be performed by one of two experienced head and neck surgeons. Inspection of larynx and pharynx will be performed to determine the extensions of the tumor in all directions. After local anesthesia, 2-4 peritumoral injections of Tc-99m-nanocolloïd will be given. Ten minutes after injection of Tc-99m-nanocolloïd a SPECT scan will be performed.
Sponsors & Collaborators
-
Radboud University Medical Center
lead OTHER
Principal Investigators
-
Hans Kaanders, MD, PhD · Radboud University Medical Center
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-09
- Primary Completion
- 2022-01-11
- Completion
- 2022-01-11
Countries
- Netherlands
Study Locations
More Related Trials
-
Vocal Cord vs Whole Laryngeal Radiotherapy for T1aN0 Glottic Cancer
NCT05679856 ·Status: UNKNOWN ·Phase: NA
-
Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer
NCT03578224 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Functional Imaging to Identify Radiosensitive Esophageal Cancer - a Biomarker Validation Study
NCT06189898 ·Status: RECRUITING
-
The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers
NCT02435602 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of Fiducial Markers in Oesophageal Cancer
NCT02403050 ·Status: UNKNOWN
-
Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy
NCT04019548 ·Status: RECRUITING ·Phase: PHASE3
-
The Value of Indocyanine Green-guided Near-infrared Fluorescence Technology in Tracing Sentinel Lymph Nodes During Esophagectomy
NCT07303231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06468644 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery (ORATOR)
NCT01590355 ·Status: UNKNOWN ·Phase: PHASE2
-
Study Evaluating Treatment of Sacituzumab-govitecan for Patients With Metastatic Esophagogastric Adenocarcinoma
NCT06123468 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Lobaplatin,5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma
NCT01034683 ·Status: UNKNOWN ·Phase: PHASE3
-
Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy
NCT01164566 ·Status: TERMINATED ·Phase: NA
-
Palliation Dysphagia Cancer Oesophagus Stent+Brachytherapy Versus Brachytherapy Only
NCT00653107 ·Status: TERMINATED ·Phase: PHASE3
-
Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
NCT00193882 ·Status: COMPLETED ·Phase: PHASE3
-
Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
NCT02642809 ·Status: COMPLETED ·Phase: PHASE1
-
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.
NCT04277858 ·Status: RECRUITING ·Phase: PHASE2
-
Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy
NCT04554771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma
NCT01586182 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis
NCT00334997 ·Status: COMPLETED ·Phase: PHASE2
-
Somatostatin Receptor Imaging in NPC, EBV Related Cancers
NCT05581550 ·Status: COMPLETED ·Phase: NA
-
Dysphagia Assessment After Swallowing Sparing RadioTherapy
NCT03448341 ·Status: COMPLETED
-
Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal Cancer
NCT01034332 ·Status: UNKNOWN ·Phase: PHASE2
-
Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma
NCT02446574 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison Study of Brachytherapy and Endoscopic Stenting for Dysphagia in Esophago-Gastric Junction Cancer
NCT01786278 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
International Nutrition Audit in FORegut TuMors
NCT02829489 ·Status: COMPLETED